Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

DH Sinn, JH Song, HJ Kim, JH Lee, HJ Son… - Digestive diseases and …, 2008 - Springer
Probiotic bacteria exhibit a variety of properties, which are unique to a particular strain.
Lactobacillus acidophilus-SDC 2012, 2013 are new strains isolated from Korean infants' …

[HTML][HTML] Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome

P Ducrotté, P Sawant, V Jayanthi - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To assess the symptomatic efficacy of Lactobacillus plantarum 299v (L. plantarum
299v)(DSM 9843) for the relief of abdominal symptoms in a large subset of irritable bowel …

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

K Niedzielin, H Kordecki… - European journal of …, 2001 - journals.lww.com
A controlled, double-blind, randomized study on the efficacy... : European Journal of
Gastroenterology & Hepatology A controlled, double-blind, randomized study on the efficacy of …

Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind …

K Preston, R Krumian, J Hattner… - Beneficial …, 2018 - wageningenacademic.com
A combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and
Lactobacillus rhamnosus CLR2 was compared to placebo for relief of symptoms of irritable …

Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome

AY Thijssen, CHM Clemens… - European journal of …, 2016 - journals.lww.com
Materials and methods IBS patients (Rome II) between 18 and 65 years of age were
included. The study consisted of an 8-week intervention period in which the participants …

[HTML][HTML] A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial

S Sadrin, S Sennoune, B Gout, S Marque… - Digestive and Liver …, 2020 - Elsevier
Background In the absence of a well-established therapeutic approach, patients with
irritable bowel syndrome seek alternative strategies such as probiotics. Aims The current …

[HTML][HTML] Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial

H Kianifar, SA Jafari, M Kiani, H Ahanchian… - Electronic …, 2015 - ncbi.nlm.nih.gov
Background: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in
children. Recently, probiotics have been suggested as a treatment option for gastrointestinal …

Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome …

C Cremon, S Guglielmetti, G Gargari… - United European …, 2018 - journals.sagepub.com
Background Evidence suggests a role of intestinal microbiota-host interactions in the
pathophysiology and symptoms of irritable bowel syndrome (IBS). Objective The objective of …

Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study

O Jadrešin, I Hojsak, Z Mišak, AJ Kekez… - Journal of pediatric …, 2017 - journals.lww.com
Objectives: Beneficial therapeutic effect of probiotics has been reported in children with the
irritable bowel syndrome (IBS) but not consistently in other functional abdominal pain …

Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis

B Tiequn, C Guanqun, Z Shuo - Internal Medicine, 2015 - jstage.jst.go.jp
Objective As the lack of reliable treatment for irritable bowel syndrome (IBS) prompts interest
in the development of new therapies, we aimed to systematically evaluate the effect of …